Cellectar Biosciences ($CLRB) CFO Chad J. Kolean made one open market purchase of company shares in the past year, totaling $25,000, with the latest on July 2, 2025. No sales reported. This activity ranks 3,634th among nearly 5,000 insiders, well below the average purchase of 1.5 million dollars across 3.3 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2025 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | P | Common Stock | 5000 | $4.99 | 6,418.0000 | 1,608,799 | 352.61% | 0.31% |
| July 2, 2025 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | P | Warrants | 5000 | $0.01 | 5,000.0000 | 1,608,799 | 9999.99% | 0.31% |
| Feb. 14, 2025 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 290000 | $0.00 | 290,000.0000 | 1,238,125 | 9999.99% | 23.42% |
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 290000 | $0.00 | 290,000.0000 | 29,346,679 | 9999.99% | 0.99% |
| Dec. 8, 2023 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | A | Common Stock | 42554 | $0.00 | 42,578.0000 | 11,308,738 | 9999.99% | 0.38% |
| June 23, 2023 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 104000 | $0.00 | 104,000.0000 | 11,261,217 | 9999.99% | 0.92% |
| Jan. 17, 2023 | Cellectar Biosciences, Inc. | $CLRB | Kolean Chad J | Chief Financial Officer | A | Stock option (right to buy) | 104000 | $0.00 | 104,000.0000 | 7,055,665 | 9999.99% | 1.47% |